New Phase 3 trial for an oral therapy

A board to discuss future MS therapies in early stage (Phase I or II) trials.

New Phase 3 trial for an oral therapy

Postby dignan » Tue Jan 11, 2005 10:44 am

Serono and IVAX to Initiate Phase III Clinical Trial of Mylinax(R) in Multiple Sclerosis

January 11, 2005 - PRNewswire-FirstCall - Serono and IVAX Corporation announced today that they will initiate a Phase III study with Mylinax(R) (a proprietary oral formulation of cladribine) in the first quarter of 2005. This multi-center, multi-national study is designed to assess the effectiveness of Mylinax(R) in patients with relapsing forms of multiple sclerosis. Endpoints will include assessments of clinical relapses, disability progression and MRI (magnetic resonance imaging) brain scans. It will be a two-year, double-blind, placebo-controlled study involving over 1,200 patients.

"As a leader in multiple sclerosis, we are committed to providing new treatment options that can further improve the quality of the lives of people with multiple sclerosis," said Ernesto Bertarelli, CEO of Serono. "With the initiation of the Phase III program of Mylinax®, we are getting closer to realizing our objective to bring the first oral disease-modifying treatment to people with multiple sclerosis."

"We are very pleased to have reached this important milestone in the development of Mylinax® as a novel therapy for multiple sclerosis," said Dr. Phillip Frost, Chairman and CEO of IVAX Corporation. "The initiation of this Phase III study supports our belief in Mylinax® and our choice of Serono as a partner that could help maximize its potential."

Previous clinical trials using a parenteral formulation demonstrated positive effects of cladribine administered via injection in patients with multiple sclerosis. In these trials, reduction in new lesion development in the brain as seen on MRI scans and clinical benefits were observed.

Mylinax® is being developed by Serono and IVAX under a worldwide agreement signed in October 2002.

About cladribine

Cladribine is a purine nucleoside analogue that interferes with the behavior and the proliferation of certain white blood cells, particularly lymphocytes, which are involved in the pathological process of multiple sclerosis. Through its differentiated mechanism of action, Mylinax® may offer an alternative option to patients with multiple sclerosis.
User avatar
Family Elder
Posts: 1608
Joined: Wed Aug 11, 2004 3:00 pm


Postby LindaR » Tue Jan 11, 2005 12:47 pm

Let's hope this works and then maybe we can toss out all of our needles.
I'm sure going to miss the bruise marks!!!!
User avatar
Family Member
Posts: 89
Joined: Tue Nov 09, 2004 4:00 pm
Location: USA - Connecticut

Application process

Postby medication » Wed Jan 12, 2005 9:10 am

Does anyone have information about where this study is going to take place and/or how someone could go about applying to become part of the study?

User avatar
Posts: 1
Joined: Thu Dec 30, 2004 4:00 pm

Postby PhireX » Tue Jan 25, 2005 5:07 am

I'm more interested to see what kind of side effects these pills give you, is it just an oral interferon, or a totally new way / method of combatting the disease?

can anyone provide any insight? I wish the people testing it would come and give us some info.. )
User avatar
Family Member
Posts: 54
Joined: Wed Jan 19, 2005 4:00 pm

Postby OddDuck » Thu Mar 10, 2005 11:41 am

I just ran across this thread!

If anybody is still wondering more about Mylinax, coincidentally, I just posted a couple of things under the thread "cladribine"!

doo doo doo doo............ I hadn't noticed this thread before I made that post today. 8O :lol:

User avatar
Contributing Author
Posts: 1040
Joined: Sat Jun 19, 2004 3:00 pm
Location: Tennessee

Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service